United States · Investor

Newpath Management

Last cheque observed May 2026; 2 cheques on record.

Email

Private equityDeploying nowNew fund, May 2026

SeedSeries ASeries BLife SciencesHealthcare

Deploying now
100%of best year1cheques in 12 months, 2 on record
Since the last cheque177days00hrs00min00sec
Median round$98MRounds led1 of 2
Pitch Newpath Management

Newpath Management highlights

  1. 01

    1 cheques in the last 12 months

  2. 02

    Mostly Series B and Series C: 100% of its rounds

  3. 03

    Led 1 rounds

What they do

Newpath Partners is a multi-stage life sciences and healthcare venture capital firm based in Boston, MA.From their own website
Type
Private equity (from a list, unverified)
Cheque size
Not stated
Stages
SeedSeries ASeries B
Sectors
Life SciencesHealthcare
Based in
Boston, United States
Cold pitches
Not stated

The record

Every round we can evidence, newest first2 appearances

  1. 2026

    1 round

  2. May
    CREATE MedicinesSeries B · US · Hatteras Venture Partners$122MLed
  3. 2023

    1 round

  4. May
    Myeloid Therapeutics, Inc.Series C · US · Hatteras Venture Partners$73MWith 5 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

The team

Named by the firm itself, on a filing, its Form ADV or its company registration1 named

TJThomas Joseph CahillCo-Founder and Managing PartneriForm ADV

We also hold 1 person at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

What the register says

From the firm's own filings with the SEC, which it must file accurately by law

$724Mgross assets of its fundsOct 2026
Exemptreporting adviserventure or small private funds
Legal name
Newpath Management, L.P.
SEC number
CRD 300064

Who they invest alongside

The investors most often in the same rounds as Newpath Management. A count of rooms they were both in, not a relationship either has claimed.

8VCVC firm2rounds togetherARCH Venture PartnersVC firm2rounds togetherHatteras Venture PartnersVC firm2rounds together

Recently backed

The latest companies Newpath Management put money into.

CREATE Medicines$122M · May 2026

Quick answers about Newpath Management

What does Newpath Management invest in?

Newpath Management invests most often at Series B and Series C (100% of the rounds on record), in sectors such as Life Sciences and Healthcare.

How active is Newpath Management?

2 investments on record, 1 of them in the last 12 months, and it led 1. The most recent was in May 2026.

What has Newpath Management invested in recently?

Its most recent investments on record: CREATE Medicines (Series B, May 2026) and Myeloid Therapeutics, Inc. (Series C, May 2023).

How big are Newpath Management's cheques?

The median round it joins is $98M.

Is Newpath Management investing now?

Yes: it is actively investing, with 1 investments in the last 12 months.

Who does Newpath Management invest alongside?

Most often 8VC (2 rounds together), ARCH Venture Partners (2 rounds together) and Hatteras Venture Partners (2 rounds together).

What kind of investor is Newpath Management?

Newpath Management is a private equity firm based in Boston, United States.

How much does Newpath Management manage?

About $724M, as gross assets of its private funds (Oct 2026).

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Find similar investorsOpen your CRM

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it